ZA891053B - Antiviral combination - Google Patents

Antiviral combination

Info

Publication number
ZA891053B
ZA891053B ZA891053A ZA891053A ZA891053B ZA 891053 B ZA891053 B ZA 891053B ZA 891053 A ZA891053 A ZA 891053A ZA 891053 A ZA891053 A ZA 891053A ZA 891053 B ZA891053 B ZA 891053B
Authority
ZA
South Africa
Prior art keywords
alpha
component
antiviral combination
interferon
preparation
Prior art date
Application number
ZA891053A
Other languages
English (en)
Inventor
J David Gangemi
David Gangemi J
Heinz-Kurt Hochkeppel
Hochkeppel Heinz-Kurt
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of ZA891053B publication Critical patent/ZA891053B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA891053A 1988-02-13 1989-02-10 Antiviral combination ZA891053B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888803365A GB8803365D0 (en) 1988-02-13 1988-02-13 Antiviral combination

Publications (1)

Publication Number Publication Date
ZA891053B true ZA891053B (en) 1989-10-25

Family

ID=10631664

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA891053A ZA891053B (en) 1988-02-13 1989-02-10 Antiviral combination

Country Status (15)

Country Link
US (1) US5137720A (fr)
EP (1) EP0329609B1 (fr)
JP (1) JP2781191B2 (fr)
KR (1) KR0131077B1 (fr)
AT (1) ATE99953T1 (fr)
AU (1) AU623876B2 (fr)
CA (1) CA1336578C (fr)
DE (1) DE68912155T2 (fr)
DK (1) DK62089A (fr)
GB (1) GB8803365D0 (fr)
IE (1) IE63493B1 (fr)
IL (1) IL89248A (fr)
NZ (1) NZ227944A (fr)
PH (1) PH26919A (fr)
ZA (1) ZA891053B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW218846B (fr) * 1992-04-07 1994-01-11 Ciba Geigy
WO1994021275A1 (fr) * 1993-03-19 1994-09-29 Vacsyn S.A. Compositions pour l'application en therapeutique humaine, caracterisees par l'association d'un muramyl-peptide a une cytokine
FR2702659B1 (fr) * 1993-03-19 1995-08-25 Vacsyn Sa Compositions pour l'application en thérapeutique humaine, caractérisées par l'association d'un muramyl-peptide à une cytokine.
US5461512A (en) * 1993-11-30 1995-10-24 Eastman Kodak Company Zoom camera lens having three moving groups
PT708085E (pt) * 1994-10-19 2002-11-29 Novartis Ag Eteres antivirais de isosteros de substrato de aspartato protease
US5786214A (en) * 1994-12-15 1998-07-28 Spinal Cord Society pH-sensitive immunoliposomes and method of gene delivery to the mammalian central nervous system
RU2140285C1 (ru) * 1999-01-25 1999-10-27 Гапонюк Петр Яковлевич Противовирусное средство - капли в нос "гриппферон"
NZ521898A (en) 2000-03-31 2004-11-26 Purdue Research Foundation Use of a ligand-immunogen conjugate such as folate-FITC for enhancing an endogenous immune response
RU2187332C1 (ru) * 2000-12-18 2002-08-20 Гапонюк Петр Яковлевич Лечебное средство
RU2185840C1 (ru) * 2001-02-06 2002-07-27 Гапонюк Петр Яковлевич Лекарственный препарат для профилактики и лечения инфекционных заболеваний
ES2338305T3 (es) * 2001-09-28 2010-05-06 Purdue Research Foundation Metodo de tratamiento que utiliza conjugados ligando-inmunogeno.
US20030180348A1 (en) * 2002-03-22 2003-09-25 Levinson R. Saul Transcellular drug delivery system
US8168164B2 (en) * 2006-02-03 2012-05-01 Purdue Research Foundation Targeted conjugates and radiation
US7625555B2 (en) * 2007-06-18 2009-12-01 Novagen Holding Corporation Recombinant human interferon-like proteins
US20080317836A1 (en) * 2007-06-19 2008-12-25 Discovery Partners Llc Topical compositions for anti-aging skin treatment
RU2488405C1 (ru) * 2012-07-17 2013-07-27 Илья Александрович Марков Лекарственное средство, обладающее противовирусным, противовоспалительным, иммуномодулирующим и обезболивающим действием, для местного и наружного применения - герпферон 2
KR101658048B1 (ko) * 2014-06-25 2016-09-20 한국생명공학연구원 포스파티딜콜린 합성경로 관여 물질을 포함하는 항바이러스용 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS616000A (ja) * 1984-06-21 1986-01-11 木下　菊巳 回転色合せ盤
DE3685996T2 (de) * 1985-06-11 1993-01-14 Ciba Geigy Ag Hybrid-interferone.
US4774085A (en) * 1985-07-09 1988-09-27 501 Board of Regents, Univ. of Texas Pharmaceutical administration systems containing a mixture of immunomodulators
AU603820B2 (en) * 1986-08-13 1990-11-29 Takeda Chemical Industries Ltd. Antitumor agent

Also Published As

Publication number Publication date
EP0329609B1 (fr) 1994-01-12
IL89248A0 (en) 1989-09-10
JPH021410A (ja) 1990-01-05
ATE99953T1 (de) 1994-01-15
EP0329609A3 (en) 1990-05-16
CA1336578C (fr) 1995-08-08
AU623876B2 (en) 1992-05-28
DK62089D0 (da) 1989-02-10
DE68912155D1 (de) 1994-02-24
GB8803365D0 (en) 1988-03-16
DE68912155T2 (de) 1994-06-16
US5137720A (en) 1992-08-11
KR890012670A (ko) 1989-09-18
NZ227944A (en) 1991-08-27
EP0329609A2 (fr) 1989-08-23
IL89248A (en) 1994-01-25
DK62089A (da) 1989-08-14
PH26919A (en) 1992-12-03
IE63493B1 (en) 1995-05-03
IE890435L (en) 1989-08-13
AU2894389A (en) 1989-08-17
KR0131077B1 (ko) 1998-04-17
JP2781191B2 (ja) 1998-07-30

Similar Documents

Publication Publication Date Title
EP0329609A3 (en) Antiviral combination
NZ215939A (en) Phosphonyl methoxyadenine antiviral compositions
IL76591A (en) Pharmaceutical compositions containing ifn-ypsilon for the treatment or prevention of malignant or viral diseases
AU591125B2 (en) Therapeutic nucleosides
NZ212632A (en) Tumor necrosis factor, its preparation and its use
ZA878877B (en) Treatment of diseases caused by viruses
EP0494231A4 (en) 6-amino-1,2-benzopyrones useful for treatment of viral diseases
EP0553294A4 (en) Methods and compositions for the treatment of cell proliferation disorders
EP0295559A3 (en) Pharmaceutical composition for the treatment of tumors
DE3572441D1 (en) Use of interferon gamma (ifn-gamma) for the production of preparations for treating rheumatic diseases
EP0294538A3 (en) Use of nigericin in the treatment of viral diseases
GR3002365T3 (en) Medicines containing as a mixture interferon and 1-desoxy-piperidinoses, process for their manufacture and their use
ZA9410381B (en) Use of Bradykinin antagonists for the preparation of medicaments for the treatment of virus diseases
AU7422387A (en) Tumor necrosis factor alpha as treatment for infectious diseases
EP0245368A4 (fr) Traitement des maladies de demyelinisation.
IL91427A0 (en) Pharmaceutical combination preparations and their use for the prophylaxis or treatment of bacterial infectious diseases
AU588493B2 (en) Treatment of diseases caused by viruses
ZA897549B (en) Medicament for the treatment of diseases caused by retroviruses
IE892593L (en) Treatment of virus diseases
IE880770L (en) Treatment of viral infections
GB8525041D0 (en) Treatment of viral infections
IL82295A0 (en) Compositions for treatment of the eyes